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Abstract
Background: We prepared an oral W/O microemulsion for the removal of colonic ammonia (ME-RCA). The effect of
this microemulsion was influenced by the digestion process in the gastrointestinal tract. In this paper, we aim to show
that stability was improved by using a microemulsion-based gel for the removal of colonic ammonia (MBG-RCA).
Methods: MBG-RCA was prepared by adding sodium alginate to the ME-RCA. MBG-RCA and ME-RCA were passed
through a simulated gastrointestinal environment, and the amount of colonic ammonia present was then
determined by titration with a standard solution of hydrochloric acid. The pH of the gastrointestinal fluid was
measured using a pH test paper and the size and form of the microemulsions were examined under the
microscope. 18 healthy rats were randomly divided into three groups, fasted for 24 hours and allowed to drink
normally. Three-way pipes were placed at the gastroduodenal junction in Group I, and at the terminal ileum in
Group II. After the intragastric administration of ME-RCA, the stomach contents in Group I, the effluent from the
terminal ileum in Group II and discharge from the anus in Group III were collected. The pH values of the
gastrointestinal juice were measured by the pH test paper and those of the colon were determined by a universal
indicator. These animal experiments were also used to test the effect of MBG-RCA.
Results: MBG-RCA showed a better removal rate of artificial colonic ammonia than ME-RCA (P < 0.05). The
decrease in pH value of the artificial small intestinal fluid due to ME-RCA did not occur when MBG-RCA was used.
In the simulated gastrointestinal process, MBG-RCA maintained greater stability and released the emulsion (ME-
RCA) in the colonic fluid. In the gastrointestinal tract of normal SD rats, ME-RCA decreased in size and lost its stable
form after entering the small intestine, while MBG-RCA remained stable and intact emulsion-drops were observed
from the anus. Neither substance had any effect on the pH of the stomach or colon of normal rats (partly because
normal rats were fasted for 24 hours and allowed to drink normally, which resulted in a low level of ammonia
production in the colon). Unlike ME-RCA, MBG-RCA did not reduce the pH of the small intestine.
Conclusions: MBG-RCA was more stable in the gastrointestinal tract and more effective at removing colonic
ammonia when a higher concentration of ammonia was present. This made it possible to achieve the targeted
removal of colonic ammonia and is a promising method to prevent hepatic encephalopathy (HE) in future studies.
Background
Ammonia intoxication theory is central in the pathogen-
esis of hepatic encephalopathy (HE) [1]. The elimination
of ammonia is the main method of preventing and treat-
ing HE [2,3]. Intestinal ammonia is mainly produced in
the colon. To date, the oral methods used to eliminate
intestinal ammonia have been ineffective. The main pro-
blem is that current methods have no significant way of
eliminating ammonia directly and the clearance rate is
low. In order to solve these problems, we prepared an
oral W/O microemulsion for the removal of ammonia
(ME-RCA). In accordance with the theory of acid-base
balance, acetic acid was used as the water phase for
ME-RCA in order to remove ammonia, an alkaline sub-
stance. In earlier experiments, it was proved that ME-
RCA is effective in eliminating ammonia, however, its
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any medium, provided the original work is properly cited.effect can be influenced by the digestive process in the
gastrointestinal tract [4]. It has been reported by some
researchers that pH-sensitive gels can swell in the colon
and release drugs due to the pH gradient in gastroin-
testinal fluids [5,6]. Therefore, we added ME-RCA to
the sodium alginate solution and prepared a microemul-
sion-based gel for the removal of ammonia (MBG-
RCA), with the aim of enhancing its stability in the
gastrointestinal tract and to achieve the colon-specific
release of the microemulsion to increase ammonia elim-
ination in the colon.
Methods
Animal care considerations
The experimental protocols were approved by the Ani-
mal Care and Use Committee of Dalian Medical Univer-
sity in accordance with guidelines established by the
Canadian Council on Animal Care.
Preparation
W/O ME-RCA and MBG-RCA were prepared by the
Membrane Science and Technology Center at the Dalian
University of Technology. The ME-RCA was prepared
using a formulation containing Tween 80 (surfactant),
ethylene glycol (cosurfactant), dimethyl silicone oil
(external oil phase), and an ammonia absorbent with a
solution of 30% acetic acid and 0.9% sodium chloride
(internal phase). The mass ratio of surfactant and cosur-
factant was 1:1, and the mass ratio of the oil and mixed
surfactant was 2:1. The W/O microemulsion system
contained a 20% water solution. The microemulsion was
added to the sodium alginate solution at a ratio of 1:1,
which was then stirred by a magnetic stirrer for 30 min-
utes to prepare MBG-RCA.
The artificial gastrointestinal fluid was prepared
according to the Chinese Pharmacopoeia, 2005 edition
[Part II List].
Pepsin (Shanghai Becky Biotechnology Co. Ltd), tryp-
sogen (Hefei Bo Mei Biotechnology Co. Ltd), urethane
(Chinese Medical Clique Chemical Reagent Company),
Sudan III (Chinese Pharmaceuticals Company), and pre-
cise pH test paper (Shanghai Sanaisi Reagent Co. Ltd)
were used in this study.
The elimination of colonic ammonia and the stability of
ME-RCA and MBG-RCA in a simulated gastrointestinal
environment
Appropriate amounts of ME-RCA or MBG-RCA (with
t h es a m ev o l u m eo fM E - R C A )w e r ea d d e dt ot h ea r t i f i -
cial liquid. The clearance rates of artificial colonic
ammonia were measured by simulating gastrointestinal
transit time and pH environment, in accordance with
the method previously described [4]. Appropriate pro-
portions (1:5) [7] of both preparations were respectively
added to the artificial gastric juice and left to stand for
2 hours. These were then added to the artificial small
intestinal fluid for 3 hours, and then the ammonical
artificial colonic fluid (10 g/L ammonia) and left to
stand for 10 hours. The ammonical lower layer was then
used in the experiments. The size and form of ME-RCA
and MBG-RCA were observed under the microscope
and the pH values in the fluids were monitored using
precise pH test paper after the fluids had been left to
stand.
Ammonia in the artificial colonic fluid was measured
according to international standards (ISO 6353/2-1983).
The quantity of ammonia was determined by titration
using a standard solution of hydrochloric acid (0.5 mol/L),
and the volume of hydrochloric acid consumed was
recorded. The quantity of ammonia in the colon: m =
0.5 × 0.01703 × V.








The above experiments were performed three times.
Stability in the gastrointestinal environment in
normal SD rats
18 SD rats were randomly divided into three groups. 6
rats in each group were fasted for 24 hours and allowed
to drink normally. ME-RCA (0.005 L/kg) was used for
intragastric administration. Intraperitoneal injections of
anesthesia (10% urethane, 1000 mg/kg) were used and
surgery was carried out at 37°C in a thermostatic water
bath kettle. A three-way pipe was placed at the gastro-
duodenal junction, and the stomach contents were col-
lected at 10 min, 20 min, 30 min, 60 min and 120 min
after emulsion administration in Group I. In Group II, a
three-way pipe was placed at the terminal ileum, and
the effluents from the small intestine were collected
5 hours after administration. In Group III, discharges
from the anus were collected when emulsion-drops
were observed. MBG-RCA (0.01 L/kg) was also used for
intragastric administration in another 18 rats. Therefore,
ME-RCA or MBG-RCA was investigated in different
segments of the gastrointestinal tract after intragastric
administration. The changes to the substances after pas-
sing through the stomach were investigated in Group I,
in the small intestine in Group II, and in the whole gas-
trointestinal tract in Group III. After staining with
Sudan III, the size and form of the collected contents in
each group were observed under the microscope. The
pH values of the gastric and small intestinal fluid were
measured using precise pH test paper before and after
intragastric administration. The pH of the colon was
measured by universal indicator-cotton stick before
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RCA was observed in discharges from the anus.
Statistical analysis
Data analysis was performed using SPSS 13.0 software.
All results are expressed as mean ± standard error of
the mean. Repeated measures analysis of variance was
used to test for differences in the pH of ME-RCA and
MBG-RCA in the simulated gastrointestinal environ-
ment and in the stomach of rats. The two-sample t-test
w a su s e dt ot e s tf o rd i f f e r e n c e si nM E - R C Aa n dM B G -
RCA in eliminating artificial colonic ammonia. The two-
sample t-test was used to test for differences in the pH
of ME-RCA and MBG-RCA in the small intestine and
colon of rats. P < 0.05 was considered statistically
significant.
Results
Comparison of the effectiveness of ME-RCA and MBG-RCA
in eliminating artificial colonic ammonia
After digestion of the enzyme-containing artificial gas-
tric and small intestinal fluid, clearance rates of ME-
RCA and MBG-RCA for ammonia in the artificial colo-
nic fluid were 51.9 ± 1.85% and 55.92 ± 4.76%, respec-
tively. The findings were statistically significant (P <
0.05), and the clearance rate of MBG-RCA was higher
than ME-RCA.
Comparison of the stability of ME-RCA and MBG-RCA in
the simulated gastrointestinal environment
Size and form
ME-RCA was seen to swell and become an emulsion in
artificial gastric fluid, and maintained a stable size in the
artificial small intestinal and colonic fluid. MBG-RCA
particles could be seen in the artificial gastric and small
intestinal fluid, and the size and form remained stable
and became emulsion-like in artificial colonic fluid.
Emulsion could be seen under the microscope, which
confirmed that ME-RCA was released in artificial colo-
nic fluid (Figure 1).
pH value
ME-RCA and MBG-RCA had no effects on the pH of
artificial gastric fluid. Both decreased the pH of artificial
small intestinal fluid, and MBG-RCA significantly
reduced the impact of pH compared with ME-RCA (P <
0.05). Both decreased the pH of artificial colonic fluid
(P < 0.05) with similar effects (Figure 2).
Comparison of the stability of ME-RCA and MBG-RCA in
the gastrointestinal tracts of normal rats
Morphologic changes
The mean diameter of ME-RCA was less than 0.1 μm.
ME-RCA swelled and became an emulsion after entering
the rat’s stomach. The emulsion droplets gradually
became larger within the first 30 min, and then
remained stable. However, they were deformed after
reaching the small intestine. Although the MBG-RCA
preparation was not optimal, we observed that the parti-
cles maintained their integrity and had no significant
changes 20 min after entering the stomach until they
reached the small intestine. Integrated W/O emulsion-
drop discharges were detected after passing through the
colon (Figure 3).
Influences on gastrointestinal Ph
The stomach pH remained unchanged when either
ME-RCA or MBG-RCA entered the stomach. The pH
value of the small intestine decreased in rats administered
ME-RCA (P < 0.05) and remained stable in those adminis-
tered MBG-RCA (P > 0.05). Neither substance had any
obvious influence on rat colon pH (P > 0.05) (Figure 4).
Discussion
We used a W/O ME-RCA prepared using acetic acid as
a trapping agent to remove ammonia in artificial colonic
fluid. The internal water phase of the emulsion was an
acetic acid solution and ammonia was absorbed into the
emulsion (the microemulsion swelled to the size and
form of the emulsion in the colon) and neutralized by
acetic acid. However, its instability in gastrointestinal
juice limits its further use in research and other applica-
tions. In this study, MBG-RCA was prepared by embed-
d i n gt h eM E - R C Ai np H - s e n s i t i v eg e lt oi m p r o v ei t s
stability.
The liquid membrane used to absorb ammonia should
be stable enough and maintain its integrity while passing
through the gastrointestinal tract until it is expelled out
of the body [8]. The ideal preparation for the targeted
elimination of ammonia in the colon should be unaf-
fected by gastric and small intestinal juice, and maintain
its integrity until it reaches the colon. Transport time
and pH of the gastrointestinal tract are the main factors
that affect the release speed and position of oral drugs,
and the stability of liquid membrane drugs. Changes in
the size and form could reflect the stability of the liquid
membrane. Because the internal water phase was acetic
acid, once it dissolves, the pH of the gastrointestinal
juice would decrease and mucosa could be damaged.
M i c r o e m u l s i o n sa r em o r es t a b l ea n dh a v eam u c h
longer shelf life than emulsions and are often used as
drug carriers in vitro. When taken orally, a microemul-
sion is diluted by the gastric juice and becomes an
emulsion. This is a key problem in maintaining the sta-
bility and character of the microemulsion when it is
used as a drug carrier[9].
In the simulated gastrointestinal environment, ME-
RCA swelled in the artificial gastric fluid and its size
and form then remained stable in the artificial small
intestinal and colonic fluid. ME-RCA had no effect on
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reduced the pH of the artificial small intestinal fluid.
We established models for the stepwise gastrointestinal
investigation by placing three-way pipes at the gastro-
duodenal junction and at the terminal ileum and collect-
ing discharges from the anus. Water and food could be
taken normally when the rats awoke from surgery. Nor-
mal gastrointestinal transit can be maintained at a maxi-
mum and observed using this method. It was observed
that ME-RCA became deformed and reduced in size,
and lowered the pH of the small intestine in normal
rats, while MBG-RCA obviously reduced these changes
compared with ME-RCA.
The reason why ME-RCA swelled in the artificial gas-
tric juice may be related to gastric fluid dilution, how-
ever, it did not result in a change in gastric juice pH.
The reason why ME-RCA led to a decrease in pH in the
small intestine may indicate a leakage of acidic sub-
stances. In order to overcome the shortcomings of ME-
RCA and allow it to pass through the stomach and
small intestine to successfully reach its objective in the
colon, we added a natural polymer, sodium alginate, to
Figure 2 MBG-RCA significantly reduced the impact of the pH of artificial small intestinal fluid compared with ME-RCA and the
influences of both on the pH of artificial ammoniacal colonic fluid
Figure 1 Size and form of ME-RCA and MBG-RCA in a simulated gastrointestinal environment in vitro.A 1-M E - R C At r a n s l u c e n t
appearance; B1 - ME-RCA in a gastrointestinal environment; C1 - ME-RCA in artificial gastric fluid (× 100); D1 - ME-RCA in small intestinal fluid (×
100); E1 - ME-RCA in colonic fluid (× 100) A2 - appearance of MBG-RCA; B2 - MBG-RCA in artificial gastric fluid and small intestinal fluid; C2 -
MBG-RCA in colonic fluid; D2 - MBG-RCA in colonic fluid under microscope (× 100) (after arriving at the stomach, the microemulsion-gel system
encountered acid and became a gel)
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Page 4 of 7Figure 3 Morphological changes of ME-RCA and MBG-RCA in the gastrointestinal tract of normal rats observed by microscopy.A 1-
Prepared ME-RCA; B1 - ME-RCA in stomach 10 min; C1 - ME-RCA in stomach 20 min; D1 - ME-RCA in stomach 30 min; E1 - ME-RCA in stomach
60 min; F1 - ME-RCA in stomach 120 min; G1 - ME-RCA in small intestine; H1 - ME-RCA in colon (× 400) A2 - Prepared MBG-RCA; B2 - MBG-RCA
in stomach 10 min; C2 - MBG-RCA in stomach 20 min; D2 - MBG-RCA in stomach 30 min; E2 - MBG-RCA in stomach 60 min; F2 - MBG-RCA in
stomach 120 min; G2 - MBG-RCA in small intestine; H2 - MBG-RCA in colon (× 400)
Figure 4 Influence of ME-RCA and MBG-RCA on pH of the stomach, small intestine and colon of normal rats.
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ME-RCA. MBG-RCA has both the advantage of a
microemulsion and a gel. This could enhance the stabi-
lity of drugs and achieve slow-release and controlled-
release of certain drugs due to its strong viscosity.
Moreover, it possesses the characteristics of an intelli-
gent gel controlled-release drug system and utilizes the
response to external pH to achieve targeted colonic
release of ME-RCA.
Gels may respond to temperature, pH, and ionic
strength, and can achieve drug release with respect to
time, quantity, or location to enhance the effects of
pharmacodynamics when intelligent polymer materials
are added to form intelligent gels. Drug release can be
controlled by swelling and shrinkage. Some researchers
have designed and synthesized a copolymerization gel
system which contains not only a pH-sensitive hydro-
philic compound but also a hydrophobic long-chain
latent compound and an azo compound that can be
degraded by bacteria. This formulation can protect the
drug from damage due to gastric enzymes and control
swelling of the gel in the small intestine by adjusting its
composition or changing the length of the hydrophobic
chain. Early release of the drug within the gel in the
small intestine can then be avoided, and the drug can
be protected until it is released in the colon when the
gel has been degraded[5,6]. A copolymer hydrogel
formed by polyvinyl alcohol and acrylic acid or
methacrylic, has a protective effect on insulin in a gas-
tric acid environment, however, it starts to release or
release a larger quantity in the alkaline conditions of the
intestine [10,11].
Alginic acid insolubilizes in the low pH environment
of the stomach, while it dissolves in the alkaline envir-
onment of the intestine and can also be degraded by
colonic enzymes. It has been widely used for the slow-
release and controlled-release of drugs[12]. Some studies
have shown that calcium alginate gel can remain stable
in gastric juice and swell in the intestinal fluid. It is a
good carrier which controls the release of materials
such as acidic drugs[13]. Chen et al[14] prepared a N,
O-carboxymethyl chitosan and alginic acid hydrogel
with a swelling ratio of 2.5 at pH 1.2 and 6.5 at pH 7.4.
Correspondingly, the quantity of encapsulated bovine
serum albumin released in acidic conditions was 20%,
while as high as 80% was released in alkaline conditions.
As a brand-new drug carrier, there is no available
research on oral microemulsion-gels for the elimination
of gut ammonia. On the basis of the studies mentioned
above, MBG-RCA was prepared according to changes in
the gastrointestinal tract pH, and thus had the advantage
of an intelligent gel with respect to pH. We found that
MBG-RCA prepared on the basis of ME-RCA was more
effective at eliminating ammonia and had greater stability
in the gastrointestinal tract. It successfully protected ME-
RCA and could pass through the stomach and small
intestine. This indicated that it would be possible to rea-
lize the objective of targeted colonic release of ME-RCA.
In this study, we did not find a change in colonic pH
when MBG-RCA was administered to normal rats. The
former experiment showed that a higher concentration of
ammonia was necessary for MBG-RCA to work well. A
significant difference in the effectiveness of oral MBG-
RCA and ME-RCA for eliminating colonic ammonia has
not been shown in animal studies because the rat model
did not include higher levels of ammonia production in
the colon. In this experiment, normal rats were fasted for
24 hours and allowed to drink normally, which led to a
low level of ammonia production in the colon. Despite
this, the desired results were achieved. The data were suf-
ficient to demonstrate that MBG-RCA was more stable in
the gastrointestinal tract than ME-RCA.
Conclusions
MBG-RCA maintained greater stability in the gastroin-
testinal tract and was more effective in the removal of
colonic ammonia when a higher concentration of colo-
nic ammonia was present. This made it possible to
achieve the targeted removal of colonic ammonia and is
a promising method for preventing HE in future studies.
The next step in our research is to continue to optimize
the composition and preparation of ME-RCA and
MBG-RCA in order to improve the removal rate of
colonic ammonia, as well as its stability in the stomach
and small intestine and pH sensitivity in the colon. An
HE animal model should be developed to investigate the
targeted removal of colonic ammonia and to determine
its effectiveness at preventing and treating HE.
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